Clinical Trials Logo

Filter by:
  • Temporarily not available  
  • Page [1]
NCT ID: NCT02606929 Temporarily not available - Multiple Sclerosis Clinical Trials

Use of Well Known Drugs for New Destination - MS Improvement (MSNT)

MSNT
Start date: January 2015
Phase: Phase 0
Study type: Expanded Access

The purpose of this expanded access retrospective study is to determine whether tetracyclines, statins and antimycotics are effective in improvement of life and health condition in the treatment of multiple sclerosis due to autoimmune disease (MS) in all his forms, specially in patients that show no response to commonly used treatments